Cllr Hanna will
provide a verbal update on relevant issues since the last meeting.
There are THREE
documents attached this item:
1. A HOSC
report containing recommendations from the Committee on the South Central
Ambulance Service’s CQC Improvement Journey, which was discussed during the 08
February 2024 HOSC meeting.
2. A HOSC
report containing recommendations from the Committee on the John Radcliffe
Hospital’s CQC Improvement Journey, which was discussed during the 08 February
2024 HOSC meeting.
3. A HOSC
report containing recommendations from the Committee on the Director of Public
Health Annual Report.
The Committee is
recommended to NOTE the Chair’s update having raised any
relevant questions.
One matter that has arisen since the
previous meeting involves the need for the Committee to agree a future
arrangement for ongoing Scrutiny of the NHS’s Oxford City Community Health Hubs
Project. It is RECOMMENDED that the Committee DELEGATES to the
Chair and Health Scrutiny Officer to establish a small HOSC Working Group to
engage in detailed and ongoing scrutiny of this project.
Minutes:
The Chair outlined the following points to update the
Committee on developments since the previous meeting:
Ø
A report (containing
recommendations from HOSC) had been submitted to the Oxford University
Hospitals NHS Foundation Trust regarding the South Central
Ambulance Service’s CQC Improvement Journey, which was discussed during the 08
February 2024 HOSC meeting
.
Ø
A HOSC report
containing recommendations from the Committee on the Director of Public Health
Annual Report could also be found in the agenda papers.
Ø
The Chair and the
Health Scrutiny Officer had requested a written briefing for the Committee
relating to the temporary closure of the ADHD referral list, with a view to
understanding the reasoning behind the closure as well as the potential impact
it could have on those affected.
Ø
The Committee had
requested a briefing from Oxford University Hospitals NHS Foundation trust on
the recent CQC maternity inspection at the Horton.
Ø
The Committee made
recommendations to the Integrated Care Board (ICB) and the parliamentary House
Select Committee regarding a new policy issued by the medicines regulator. This
policy pertained to anti-seizure medication and medication used for individuals
with bipolar disorder called Valproate. As an update to that, the ICB
established a task force comprising consultants, specialist nurses, medicines
safety officers, representatives from charities and patients with lived
experiences. The impact report outlined that there were unavoidable
consequences, and current services were ill-equipped to handle the
implementation of phase one of the medicines regulatory policy.
Specifically, it was
anticipated that approximately 2,855 outpatient appointments would be lost due
to the new requirements.
The report further predicted
that reduced access would lead to increased mortality and greater morbidity,
including emergency situations arising from uncontrolled epilepsy. Notably,
this assessment did not encompass the impacts and risks associated with phase
two of the policy, which could be even more significant.
Ø
The Chair also paid
tribute to the Senior Patient Safety Manager at the ICB for his leadership of
this taskforce, and the Committee offered their condolences to his family and
colleagues.
The Committee NOTED the Chair’s Update.
The
Committee AGREED the following actions:
Supporting documents: